do glp 1 agonists cause muscle loss matters: the effects of medically induced weight on skeletal muscle Muscle Loss with GLP-1 Medications:
Description
Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease
/assets/images/provider/photos/2775923.jpeg)
This anorectic action allowed GLP-1 RAs to be approved for the treatment of obesity, also in the absence of T2DM [16,17]
Diabetic ketoacidosis In patients with insulindependent diabetes, the risk of DKA is the primary concern

Cannon CP, Pratley R, Dagogo-Jack S, et al

The suppression of food intake and resulting weight loss provides essential advantages for patients who struggle with obesity or complications from excessive weight [6]

Ultimately, the choice depends on the patients lifestyle and personal preference, Ali added
